Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 142
- +22 vs. Q4 2023
- Shares held
- 85.3M
- +4.22M (+5.2%) vs. Q4 2023
- Total value
- $1.34B
- +$116.0M (+9.4%) vs. Q4 2023
- New holders
- 36
- 44 more added
- Sold out
- 14
- 37 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carson Advisory Inc. | 12,770 | $201.3K | 0.14% | +12,770 | New |
| Cornercap Investment Counsel Inc | 12,582 | $198.3K | 0.03% | +12,582 | New |
| Raymond James & Associates | 12,113 | $190.9K | 0.00% | +12,113 | New |
| Kennedy Capital Management, Inc. | 11,978 | $188.8K | 0.00% | +11,978 | New |
| Creative Planning | 11,590 | $182.7K | 0.00% | +590+5.4% | Added |
| OneAscent Financial Services LLC | 11,427 | $180.0K | 0.02% | +1,103+10.7% | Added |
| Teacher Retirement System of Texas | 11,028 | $174.0K | 0.00% | −397−3.5% | Reduced |
| 49 Wealth Management, LLC | 10,662 | $172.0K | 0.04% | +10,662 | New |
| XTX Topco Ltd | 10,611 | $167.2K | 0.02% | +10,611 | New |
| Gsa Capital Partners LLP | 10,602 | $167.0K | 0.01% | +10,602 | New |
| Erste Asset Management GmbH | 9,800 | $148.9K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 9,300 | $146.6K | 0.04% | +9,300 | New |
| Point72 (DIFC) Ltd | 9,043 | $142.5K | 0.01% | +9,043 | New |
| Ameritas Investment Partners, Inc. | 5,837 | $92.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 5,790 | $91.3K | 0.05% | −399−6.4% | Reduced |
| Great West Life Assurance Co | 5,018 | $79.0K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 3,392 | $53.5K | 0.01% | +3,392 | New |
| Metropolitan Life Insurance Co | 3,388 | $53.4K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,882 | $46.0K | 0.00% | −14,645−83.6% | Reduced |
| Amalgamated Bank | 1,987 | $31.0K | 0.00% | −6,309−76.0% | Reduced |
| Pacer Advisors, Inc. | 1,386 | $21.8K | 0.00% | +1,386 | New |
| Quest Partners LLC | 1,357 | $21.4K | 0.00% | −1,125−45.3% | Reduced |
| EverSource Wealth Advisors, LLC | 1,610 | $17.8K | 0.00% | +565+54.1% | Added |
| Nisa Investment Advisors, LLC | 686 | $10.8K | 0.00% | +121+21.4% | Added |
| US Bancorp | 650 | $10.2K | 0.00% | −8−1.2% | Reduced |
| Cutler Group LP | 600 | $9.00K | 0.00% | −300−33.3% | Reduced |
| Advisor Group Holdings, Inc. | 331 | $5.21K | 0.00% | −320−49.2% | Reduced |
| Daiwa Securities Group Inc. | 212 | $3.00K | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 130 | $2.05K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 119 | $1.88K | 0.00% | +119 | New |
| Proequities, Inc. | 100 | $1.58K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 64 | $1.01K | 0.00% | −3,551−98.2% | Reduced |
| CWM, LLC | 39 | $1.00K | 0.00% | +39 | New |
| Signaturefd, LLC | 47 | $741 | 0.00% | +17+56.7% | Added |
| Versant Capital Management, Inc | 46 | $725 | 0.00% | +46 | New |
| GAMMA Investing LLC | 26 | $410 | 0.00% | +7+36.8% | Added |
| Riggs Asset Managment Co. Inc. | 23 | $363 | 0.00% | +23 | New |
| FinTrust Capital Advisors, LLC | 17 | $263 | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 11 | $173 | 0.00% | +11 | New |
| Farther Finance Advisors, LLC | 10 | $161 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 10 | $158 | 0.00% | +10 | New |
| Covestor Ltd | 7 | $0 | 0.00% | +3+75.0% | Added |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −194,933−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −175,537−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −152,747−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −125,727−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −68,791−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −50,202−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −40,156−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −33,350−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −31,078−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −29,905−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −28,608−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −7,355−100.0% | Sold out |
| Arlington Trust Co LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |